Bausch + Lomb Corporation (BLCO) financial statements and ratios from SEC XBRL: revenue $5.3B (TTM), net margin -7.1%, revenue growth 9.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $5.10B |
| Revenue (TTM) | $5.3B |
| Net Margin | -7.1% |
| Operating Margin (TTM) | 6.1% |
| Net Debt / EBITDA | 5.6 |
| Revenue Growth (YoY) | 9.1% |
| EPS Growth (YoY) | -77.8% |
| FCF Growth (YoY) | -251.9% |
| EV / EBITDA | 15.0 |
| Price / Book | 1.00 |
| Price / Sales | 1.21 |
| FCF Yield | -1.0% |
| Altman Z-Score | 0.90 (distress) |
| Industry P/E (Medical Equipment) | 29.8 |
| Sector P/E (Healthcare) | 21.6 |
BLCO overview · BLCO earnings · BLCO KPIs · BLCO documents · BLCO ownership · BLCO peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.